![]() |
MD in 1980, Complutense University Medical School, Madrid, Spain Medical Oncology speciality, Hôpital Paul Brousse, Villejuif, France. PhD Cum Laudem, University Paris Sud XI in December 1991. Clinical Co-author of more than 90 manuscripts covering mainly clinical and translational research in gastrointestinal and brain tumours. Past Head of the Medical Oncology Department at Carlos Haya University Hospital in Málaga, Spain (2006 - 2014). Past Head of the Translational Oncology Group in the Carlos Haya University Hospital for the Biomedicine Institute of Málaga (IBIMA). Currently President of the Spanish Cooperative Group for the treatment and research of brain tumours (GEINO) and member of the steering commitee of the Spanish Cooperative Group for the treatment of digestive tumours (TTD). Member of the editorial board of peer-reviewed journals, and member of the main medical oncology societies (ASCO, ESMO, SEOM, SAOM). |
-
Glioblastoma: Does the pre-treatment geometry matter? A postcontrast T1 MRI-based study
European Radiology 27(3), 1096-1104 (2017)
J. Pérez-Beteta, A. Martínez-González, D. Molina, M. Amo, B. Luque, E. Arregui, M. Calvo, J. M. Borrás, C. López, M. Claramonte, J. Barcia, L. Iglesias, J. Avecillas, D.Albillo, M. Navarro, J.M. Villanueva, J.C. Paniagua, J. Martino, C. Velasquez, B. Asenjo, M. Benavides, I. Herruzo, M.C. Delgado, A. Del Valle, A. Falkov, P. Schucht, E. Arana, L. Pérez-Romasanta, V. M.Pérez-García -
Towards individualized survival prediction in glioblastoma patients using machine learning methods
Neuro-Oncology 19(3):iii84-iii84 (2017)
L. Vera, J. Pérez-Beteta, D. Molina, J.M. Borrás, M. Benavides, J.A. Barcia, C. Velásquez, D. Albillo, P. Lara, V.M. Pérez-García
![](https://molab.es/timthumb.php?w=230&h=310&zc=1&src=https://molab.es/imaci/wp-content/uploads/2018/09/ManuelBenavides2-783x1024.jpg)
MD in 1980, Complutense University Medical School, Madrid, Spain Medical Oncology speciality, Hôpital Paul Brousse, Villejuif, France. PhD Cum Laudem, University Paris Sud XI in December 1991. Clinical Co-author of more than 90 manuscripts covering mainly clinical and translational research in gastrointestinal and brain tumours. Past Head of the Medical Oncology Department at Carlos Haya University Hospital in Málaga, Spain (2006 - 2014). Past Head of the Translational Oncology Group in the Carlos Haya University Hospital for the Biomedicine Institute of Málaga (IBIMA). Currently President of the Spanish Cooperative Group for the treatment and research of brain tumours (GEINO) and member of the steering commitee of the Spanish Cooperative Group for the treatment of digestive tumours (TTD). Member of the editorial board of peer-reviewed journals, and member of the main medical oncology societies (ASCO, ESMO, SEOM, SAOM). |
- Glioblastoma: Does the pre-treatment geometry matter? A postcontrast T1 MRI-based study
European Radiology 27(3), 1096-1104 (2017)
J. Pérez-Beteta, A. Martínez-González, D. Molina, M. Amo, B. Luque, E. Arregui, M. Calvo, J. M. Borrás, C. López, M. Claramonte, J. Barcia, L. Iglesias, J. Avecillas, D.Albillo, M. Navarro, J.M. Villanueva, J.C. Paniagua, J. Martino, C. Velasquez, B. Asenjo, M. Benavides, I. Herruzo, M.C. Delgado, A. Del Valle, A. Falkov, P. Schucht, E. Arana, L. Pérez-Romasanta, V. M.Pérez-García - Towards individualized survival prediction in glioblastoma patients using machine learning methods
Neuro-Oncology 19(3):iii84-iii84 (2017)
L. Vera, J. Pérez-Beteta, D. Molina, J.M. Borrás, M. Benavides, J.A. Barcia, C. Velásquez, D. Albillo, P. Lara, V.M. Pérez-García